For the SDC2 gene alone, the performance was less efficient than the ColoCaller test, even in the entire cohort with less sensitivity (93.30% vs 95.60%) for CRC screening (Supplementary Table 3). This evidence concerns the gene SDC2 and colorectal carcinoma.